Details of the Drug
General Information of Drug (ID: DM47F9I)
Drug Name |
PT-101
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Thiourea, N-(2-phenylethyl)-N'-2-pyridinyl-; 5454-38-6; 1-phenethyl-3-pyridin-2-ylthiourea; NSC23099; PT-101; AC1Q7ELP; AC1LGQ0C; MLS000665556; CHEMBL316796; SCHEMBL6952754; DTXSID80202964; MolPort-001-516-695; ZINC306266; HMS2563B19; 1-phenethyl-3-(2-pyridyl)thiourea; NSC-23099; STK027846; AKOS002320458; MCULE-6942162011; NCGC00245645-01; SMR000270803; N-(2-phenylethyl)-N'-2-pyridinylthiourea; KB-219590; 1-(2-phenylethyl)-3-pyridin-2-ylthiourea; ST50594514; SR-01000246008; SR-01000246008-1
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 257.36 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||